Piramal Pharma Limited (NSE:PPLPHARMA)
India flag India · Delayed Price · Currency is INR
176.70
+4.71 (2.74%)
Jul 10, 2026, 3:30 PM IST

Piramal Pharma Company Description

Piramal Pharma Limited operates as a pharmaceutical company in the United States, Europe, Japan, India, and internationally.

The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities.

It also operates contract development and manufacturing organization that provides services across the drug life cycle, including discovery, development, and commercial manufacturing; offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain management drugs, and other generic and speciality products; and analgesics, skin care, vitamin and mineral supplement, kids’ wellness, digestives, and women’s health, as well as geriatric care.

The company was incorporated in 2020 and is based in Mumbai, India.

Piramal Pharma Limited
CountryIndia
Founded2020
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees7,120

Contact Details

Address:
Ananta Building
Mumbai, Maharashtra 400 070
India
Phone91 22 3802 3000
Websitepiramalpharma.com

Stock Details

Ticker SymbolPPLPHARMA
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE0DK501011
SIC Code2834

Key Executives

NamePosition
Peter Daniel DeYoungChief Executive Officer of Piramal Global Pharma and Director
Nandini Ajay PiramalExecutive Chairperson
Vivek ValsarajChief Financial Officer and Executive Director
Vinay AgarwalSenior Vice President of Operations
Viral GandhiPresident and Group CIO of Piramal Group
Gagan BoranaHead of Investor Relations and Sustainability
Sandeep K. RathodGeneral Counsel
Maneesh SharmaCompany Secretary and Compliance Officer
Prashanth M. S.Vice President of Sales
Puneet RajputChief Human Resources Officer